Dow Up 0.08% Nasdaq Down 0.30%

Dendreon Corp. (DNDN)

-NasdaqGS
1.50 Up 0.08(5.63%) Sep 19, 4:00PM EDT
|After Hours : 1.50 0.00 (0.00%) Sep 19, 7:56PM EDT
Prev Close:1.42
Open:1.46
Bid:1.50 x 3000
Ask:1.55 x 500
1y Target Est:1.90
Beta:3.89
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:1.38 - 1.59
52wk Range:1.24 - 3.52
Volume:11,993,714
Avg Vol (3m):2,411,160
Market Cap:233.14M
P/E (ttm):N/A
EPS (ttm):-1.71
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DNDNUp 5.63%233.14M
NWBODown 3.88%324.30M
PGNXDown 2.68%353.34M
SNYDown 0.51%148.77B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):0.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.74
Quarterly EPS Est (Sep-14) :-0.20
Mean Recommendation*:3.7
PEG Ratio (5 yr expected):-0.02

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dendreon Corporation, a biotechnology company, focuses on the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback